Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tertiary Cancer Center
100%
Ocular Graft-versus-host Disease
100%
Treatment Burden
66%
MD Anderson Cancer Center
33%
Patient-reported Outcomes
33%
Clinical Presentation
33%
Targeted Therapy
33%
Therapeutic Strategies
33%
Surgical Intervention
33%
Treatment Strategy
33%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
Tissue-like
33%
Vision Loss
33%
Ocular Tissues
33%
Treatment Protocol
33%
Early Recognition
33%
Ocular Surface
33%
Clinical Pathophysiology
33%
Diagnostic Uncertainty
33%
Ocular Findings
33%
Delayed Recognition
33%
Lubricant
33%
Diagnostic Challenges
33%
Topical Immunomodulators
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Graft Versus Host Reaction
100%
Targeted Therapy
33%
Morbidity
33%
Pathophysiology
33%
Allogeneic Hematopoietic Stem Cell Transplantation
33%
Immunomodulating Agent
33%
Visual Impairment
33%
Ocular Surface
33%
Lubricating Agent
33%
Patient-Reported Outcome
33%
Nursing and Health Professions
Cancer Center
100%
Graft Versus Host Reaction
100%
Patient-Reported Outcome
33%
Morbidity
33%
Immunomodulating Agent
33%
Pathophysiology
33%
Allogeneic Hematopoietic Stem Cell Transplantation
33%
Visual Impairment
33%
Lubricating Agent
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Graft Versus Host Reaction
100%
Pathophysiology
33%
Visual Impairment
33%
Immunomodulating Agent
33%
Morbidity
33%
Lubricating Agent
33%
Neuroscience
Hematopoietic Cell
100%
Immunomodulating Drug
100%